Keryx Biopharmaceuticals to Webcast its Presentations at Investor Healthcare Conferences in November 2017
November 08 2017 - 4:16PM
Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical
company focused on bringing innovative medicines to people with
kidney disease, today announced it will webcast corporate
presentations at the following investor conferences in November:
- Stifel’s 2017 Healthcare Conference in New York City on
Tuesday, November 14, 2017 at 3:30 p.m. ET
- Jefferies’ 2017 Global Healthcare Conference in London, UK, on
Thursday, November 16, 2017 at 8:40 a.m. GMT (3:40 a.m. ET)
- A fireside chat at the 29th Annual Piper Jaffray Healthcare
Conference in New York City on Tuesday, November 28, 2017 at 2:00
p.m. ET
Live audio webcasts of the presentations will be
accessible from Keryx Biopharmaceuticals’ website at
http://investors.keryx.com within the Investor Relations section
under “webcasts and presentations.” An archived version of the
webcast will be available for at least 15 days following the
conclusion of the live presentations.
About Keryx Biopharmaceuticals,
Inc.Keryx Biopharmaceuticals, Inc., with headquarters in
Boston, Massachusetts, is focused on the development and
commercialization of innovative medicines that provide unique and
meaningful advantages to people with kidney disease. The Keryx team
consists of more than 200 committed people working with passion to
advance the care of people with this complex disease. This
dedication has resulted in two FDA-approved indications for Keryx’s
first medicine, Auryxia® (ferric citrate) tablets.
KERYX BIOPHARMACEUTICALS
CONTACT:Lora PikeSenior Director, Investor Relations &
Corporate CommunicationsT: 617-466-3511lora.pike@keryx.com
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Sep 2023 to Sep 2024